{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:14:48Z","timestamp":1794111288674,"version":"4.8.0"},"reference-count":81,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,12,9]]},"abstract":"<jats:sec id=\"ab-jrv250028-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Superficial vein thrombosis (SuVT) is characterized by thrombus in the superficial veins, typically in the lower or upper extremities, and has an estimated annual incidence of 64 to 131 per 100\u202f000 person-years. Approximately 10% of patients with SuVT progress to deep vein thrombosis (DVT) or pulmonary embolism (PE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv250028-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Endothelial injury (caused by infection or intravenous devices), venous stasis (such as from chronic venous insufficiency or prolonged immobility), and hypercoagulability (due to cancer or pregnancy) are pathophysiologic factors associated with SuVT. Clinical risk factors for lower extremity SuVT are similar to those of DVT and PE and include pregnancy, varicose veins, and active cancer. The incidence of SuVT is greater in females than males (78-167 compared with 49-116 per 100\u202f000 person-years). In contrast with lower extremity SuVT, upper extremity SuVT is primarily caused by indwelling intravenous catheters. Patients typically present with a tender, red, palpable cord under the skin in the upper or lower extremity. D-dimer testing has a sensitivity of approximately 48% to 74.3% and, therefore, is not reliable for excluding SuVT. Approximately 25% of patients with lower extremity SuVT present with concomitant DVT, likely because risk factors for SuVT and DVT are similar and because SuVT can extend into deep veins. In people without classic symptoms and signs of SuVT, ultrasonography can establish the presence and extent of the thrombus. Management may include elastic compression stockings and nonsteroidal anti-inflammatory drugs. For patients with SuVTs that are at least 5 cm long or those with persistent or worsening symptoms despite several days of conservative therapy, treatment includes anticoagulation with fondaparinux 2.5 mg. Alternative anticoagulation treatment includes rivaroxaban 10 mg once daily and low-molecular-weight heparins (eg, enoxaparin 40 mg once daily), which may reduce subsequent venous thromboembolic events. SuVT located within 3 cm of a deep vein should be treated with therapeutic doses of anticoagulation such as direct oral anticoagulants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv250028-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>SuVT typically presents as a tender, painful, palpable cord under the skin. Management may include elastic compression stockings, nonsteroidal anti-inflammatory drugs, and systemic anticoagulation with fondaparinux 2.5 mg or rivaroxaban 10 mg. SuVTs within 3 cm of a deep vein should be treated with therapeutic dose anticoagulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2025.15222","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:00:36Z","timestamp":1757948436000},"page":"2020","source":"Crossref","is-referenced-by-count":27,"title":["Superficial Vein Thrombosis"],"prefix":"10.1001","volume":"334","author":[{"given":"Gregory","family":"Piazza","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darsiya","family":"Krishnathasan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Hamade","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ujueta","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scimeca","sequence":"additional","affiliation":[{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos D.","family":"Ortiz-Rios","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"McGonagle","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Galanaud","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Servicio de Neumolog\u00eda, Hospital Ram\u00f3n y Cajal e Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS), Madrid, Spain"},{"name":"Departamento de Medicina, Universidad de Alcal\u00e1, Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Monreal","sequence":"additional","affiliation":[{"name":"Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM, Universidad Cat\u00f3lica San Antonio de Murcia, Murcia, Spain"},{"name":"CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fanikos","sequence":"additional","affiliation":[{"name":"North American Thrombosis Forum, Brookline, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Dua","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, Department of Surgery, Massachusetts General Hospital\/Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leben","family":"Tefera","sequence":"additional","affiliation":[{"name":"Vascular Medicine, Cleveland Clinic Main Campus, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Kolluri","sequence":"additional","affiliation":[{"name":"Heart and Vascular Service, OhioHealth Riverside Methodist Hospital, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil A.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[{"name":"Medicine and Surgery, University of Insubria, Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[{"name":"Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, and McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Moores","sequence":"additional","affiliation":[{"name":"Department of Medicine, F. Edward Hebert School of Medicine, The Uniformed Services University of the Health Sciences, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Qu\u00e9r\u00e9","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Vasculaire, CHU Montpellier, UMR UA11 INSERM IDESP \u2013 Montpellier University, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Thrombosis Research Group, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"jrv250028r1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/jth.12575","article-title":"Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study.","volume":"12","author":"Frapp\u00e9","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"jrv250028r2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019967","article-title":"Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands.","volume":"8","author":"Geersing","year":"2018","journal-title":"BMJ Open"},{"issue":"6","key":"jrv250028r3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1055\/s-0040-1722189","article-title":"Incidence of venous thromboembolism in a racially diverse population of Oklahoma County, Oklahoma.","volume":"121","author":"Wendelboe","year":"2021","journal-title":"Thromb Haemost"},{"issue":"7","key":"jrv250028r4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0268355516653005","article-title":"Hospital incidence and annual rates of hospitalization for venous thromboembolic disease in France and the USA.","volume":"32","author":"Allaert","year":"2017","journal-title":"Phlebology"},{"issue":"5","key":"jrv250028r5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjh.13255","article-title":"Superficial vein thrombosis: a current approach to management.","volume":"168","author":"Scott","year":"2015","journal-title":"Br J Haematol"},{"issue":"13","key":"jrv250028r7","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1056\/NEJMoa0912072","article-title":"Fondaparinux for the treatment of superficial-vein thrombosis in the legs.","volume":"363","author":"Decousus","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"jrv250028r8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1538-7836.2012.04727.x","article-title":"A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).","volume":"10","author":"Cosmi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"7","key":"jrv250028r9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/jth.12986","article-title":"Management of superficial vein thrombosis.","volume":"13","author":"Cosmi","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"jrv250028r11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.thromres.2013.12.005","article-title":"Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).","volume":"133","author":"Cosmi","year":"2014","journal-title":"Thromb Res"},{"issue":"6","key":"jrv250028r12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/jth.13679","article-title":"Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.","volume":"15","author":"Galanaud","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"5","key":"jrv250028r13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ejvs.2023.08.031","article-title":"Determinants of late venous thromboembolic events after acute isolated superficial vein thrombosis in daily practice: 12 month results of the INSIGHTS-SVT Study.","volume":"66","author":"Rabe","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"jrv250028r14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejvs.2021.04.015","article-title":"Management and outcomes of patients with isolated superficial vein thrombosis under real life conditions (INSIGHTS-SVT).","volume":"62","author":"Bauersachs","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"12","key":"jrv250028r16","first-page":"847","article-title":"Risk factors for superficial thrombophlebitis: a retrospective case control study.","volume":"25","author":"Schamroth Pravda","year":"2022","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"jrv250028r17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s11239-024-02963-6","article-title":"Superficial vein thrombosis and its relationship with malignancies: a prospective observational study.","volume":"57","author":"D\u00edez-Vidal","year":"2024","journal-title":"J Thromb Thrombolysis"},{"issue":"17","key":"jrv250028r18","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1182\/blood-2011-06-364232","article-title":"The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs.","volume":"118","author":"Prandoni","year":"2011","journal-title":"Blood"},{"issue":"5","key":"jrv250028r19","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1016\/S2352-3026(23)00013-3","article-title":"Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period: a Danish nationwide cohort study.","volume":"10","author":"Wiegers","year":"2023","journal-title":"Lancet Haematol"},{"issue":"3","key":"jrv250028r20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0310057X8801600305","article-title":"Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use.","volume":"16","author":"Gaukroger","year":"1988","journal-title":"Anaesth Intensive Care"},{"issue":"7","key":"jrv250028r21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/j.1538-7836.2005.01458.x","article-title":"The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism.","volume":"3","author":"Di Minno","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"9","key":"jrv250028r22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/0268355517748540","article-title":"Tinzaparin in intermediate dose for the treatment of superficial vein thrombosis: results from an observational multicenter study-SeVEN study.","volume":"33","author":"Giannoukas","year":"2018","journal-title":"Phlebology"},{"issue":"6","key":"jrv250028r23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/0268355520947300","article-title":"Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: a real word cohort study: the SeVEN EXTension study.","volume":"36","author":"Karathanos","year":"2021","journal-title":"Phlebology"},{"issue":"1","key":"jrv250028r24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1160\/TH10-06-0406","article-title":"Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis: the OPTIMEV study.","volume":"105","author":"Galanaud","year":"2011","journal-title":"Thromb Haemost"},{"issue":"1","key":"jrv250028r25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jvsv.2021.05.006","article-title":"Prevalence of cancer in patients with superficial vein thrombosis and its clinical importance.","volume":"10","author":"Hirmerov\u00e1","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"6","key":"jrv250028r26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1160\/TH13-11-0925","article-title":"Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs.","volume":"111","author":"Legnani","year":"2014","journal-title":"Thromb Haemost"},{"key":"jrv250028r27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.avsg.2017.02.022","article-title":"An unexpectedly high rate of thrombophilia disorders in patients with superficial vein thrombosis of the lower extremities.","volume":"43","author":"Sobreira","year":"2017","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"jrv250028r28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/ATVBAHA.109.184127","article-title":"Venous thromboembolism in pregnancy.","volume":"29","author":"James","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"jrv250028r29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/0002-9378(67)90565-0","article-title":"Acute superficial venous thrombophlebitis associated with pregnancy.","volume":"97","author":"Aaro","year":"1967","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"jrv250028r30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy.","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"jrv250028r31","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620939181","article-title":"Position paper on the management of pregnancy-associated superficial venous thrombosis.","volume":"28","author":"Antic","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"jrv250028r32","first-page":"IV3","article-title":"The changing clinical spectrum of thromboangiitis obliterans (Buerger\u2019s disease).","volume":"82","author":"Olin","year":"1990","journal-title":"Circulation"},{"issue":"12","key":"jrv250028r33","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1056\/NEJM200009213431207","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease).","volume":"343","author":"Olin","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv250028r34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0002-9343(02)01163-4","article-title":"The epidemiology of peripheral vein infusion thrombophlebitis: a critical review.","volume":"113","author":"Tagalakis","year":"2002","journal-title":"Am J Med"},{"issue":"12","key":"jrv250028r35","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/bjs.1800751223","article-title":"Effect of transdermal glyceryl trinitrate on the survival of peripheral intravenous infusions: a double-blind prospective clinical study.","volume":"75","author":"Khawaja","year":"1988","journal-title":"Br J Surg"},{"issue":"8","key":"jrv250028r36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jvir.2010.04.020","article-title":"Prospective randomized comparative evaluation of proximal valve polyurethane and distal valve silicone peripherally inserted central catheters.","volume":"21","author":"Ong","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"jrv250028r37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejca.2016.02.011","article-title":"Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.","volume":"59","author":"Wildgruber","year":"2016","journal-title":"Eur J Cancer"},{"issue":"6","key":"jrv250028r38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018996","article-title":"A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis.","volume":"99","author":"Ploton","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"jrv250028r39","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jvs.2004.07.025","article-title":"Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France.","volume":"40","author":"Carpentier","year":"2004","journal-title":"J Vasc Surg"},{"issue":"3","key":"jrv250028r40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.contraception.2015.03.010","article-title":"Superficial venous disease and combined hormonal contraceptives: a systematic review.","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"issue":"7","key":"jrv250028r41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archdermatol.2009.123","article-title":"Association between superficial vein thrombosis and deep vein thrombosis of the lower extremities.","volume":"145","author":"Binder","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"jrv250028r42","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0741-5214(96)70007-1","article-title":"Progression of superficial venous thrombosis to deep vein thrombosis.","volume":"24","author":"Chengelis","year":"1996","journal-title":"J Vasc Surg"},{"issue":"4","key":"jrv250028r43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7326\/0003-4819-152-4-201002160-00006","article-title":"Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study.","volume":"152","author":"Decousus","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"jrv250028r44","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1538-7836.2005.01445.x","article-title":"Superficial thrombophlebitis of the legs: still a lot to learn.","volume":"3","author":"Decousus","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"5","key":"jrv250028r45","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/jth.13279","article-title":"Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.","volume":"14","author":"Di Minno","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"1","key":"jrv250028r46","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102263","article-title":"Management and outcomes of superficial vein thrombosis: a single-center retrospective study.","volume":"8","author":"Mathieu","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"jrv250028r47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011015.pub2","article-title":"Treatment for superficial infusion thrombophlebitis of the upper extremity.","volume":"2015","author":"Di Nisio","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"jrv250028r48","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102391","article-title":"Incidence and clinical progression of asymptomatic peripherally inserted central catheter-related thrombosis in solid neoplasm patients: ultrasound insights from a prospective cohort study.","volume":"8","author":"Cominacini","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"jrv250028r49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-2005-921948","article-title":"Lower extremity venous anatomy.","volume":"22","author":"Meissner","year":"2005","journal-title":"Semin Intervent Radiol"},{"issue":"7","key":"jrv250028r50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/DAD.0b013e3181d7759d","article-title":"The misdiagnosis of superficial thrombophlebitis as cutaneous polyarteritis nodosa: features of the internal elastic lamina and the compact concentric muscular layer as diagnostic pitfalls.","volume":"32","author":"Chen","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"jrv250028r51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.7326\/0003-4819-140-8-200404200-00005","article-title":"D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.","volume":"140","author":"Stein","year":"2004","journal-title":"Ann Intern Med"},{"issue":"12","key":"jrv250028r52","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.amjmed.2005.06.044","article-title":"D-dimer is not useful for the diagnosis of isolated superficial venous thrombosis.","volume":"118","author":"Aguilar","year":"2005","journal-title":"Am J Med"},{"issue":"6","key":"jrv250028r53","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1002\/nop2.998","article-title":"D-dimer level for ruling out peripherally inserted central catheter-associated upper extremity deep vein thrombosis and superficial vein thrombosis.","volume":"9","author":"Liu","year":"2022","journal-title":"Nurs Open"},{"key":"jrv250028r54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmv.2007.01.111","author":"Gillet","year":"2007","journal-title":"J Mal Vasc"},{"issue":"3","key":"jrv250028r55","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2352-3026(17)30014-5","article-title":"Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.","volume":"4","author":"Beyer-Westendorf","year":"2017","journal-title":"Lancet Haematol"},{"issue":"14","key":"jrv250028r56","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/archinte.163.14.1657","article-title":"A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.","volume":"163","author":"Superficial Thrombophlebitis Treated By Enoxaparin Study Group","year":"2003","journal-title":"Arch Intern Med"},{"issue":"4","key":"jrv250028r57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ejvs.2014.06.047","article-title":"Therapeutic effect of compression stockings versus no compression on isolated superficial vein thrombosis of the legs: a randomized clinical trial.","volume":"48","author":"Boehler","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"jrv250028r58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/153857440303700605","article-title":"Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study.","volume":"37","author":"Lozano","year":"2003","journal-title":"Vasc Endovascular Surg"},{"issue":"10","key":"jrv250028r60","doi-asserted-by":"publisher","first-page":"E391","DOI":"10.1503\/cmaj.131281","article-title":"Graduated compression stockings.","volume":"186","author":"Lim","year":"2014","journal-title":"CMAJ"},{"key":"jrv250028r61","doi-asserted-by":"publisher","first-page":"16S","DOI":"10.1177\/0003319706297740","article-title":"Topical heparin: new observations.","volume":"58","author":"Cesarone","year":"2007","journal-title":"Angiology"},{"issue":"10","key":"jrv250028r62","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47418","article-title":"Review of topical sodium heparin 1000 iu\/g gel in symptomatic uncomplicated superficial thrombophlebitis.","volume":"15","author":"Cabr\u00e9","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"jrv250028r63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004982.pub5","article-title":"Treatment for superficial thrombophlebitis of the leg.","author":"Di Nisio","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"jrv250028r64","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1538-7836.2005.01391.x","article-title":"High vs low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial.","volume":"3","author":"Prandoni","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"6","key":"jrv250028r65","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30062-5","article-title":"Evaluation of direct oral anticoagulants in superficial-vein thrombosis.","volume":"4","author":"Frapp\u00e9","year":"2017","journal-title":"Lancet Haematol"},{"issue":"3","key":"jrv250028r66","first-page":"160","article-title":"[Therapeutic management of superficial venous thrombosis with calcium nadroparin: dosage testing and comparison with a non-steroidal anti-inflammatory agent].","volume":"43","author":"Titon","year":"1994","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"8","key":"jrv250028r67","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-024-01003-3","article-title":"Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.","volume":"21","author":"Talasaz","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"jrv250028r68","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2013.04.007","author":"Brown","year":"2013","journal-title":"Surg Clin North Am"},{"issue":"6","key":"jrv250028r69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2024.101917","article-title":"Varicose vein surgery after acute isolated superficial vein thrombosis in daily practice: INSIGHTS-SVT study.","volume":"12","author":"Noppeney","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"jrv250028r70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2023.08.011","article-title":"The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities: part II: endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine.","volume":"12","author":"Gloviczki","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"jrv250028r71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdmv.2018.12.178","author":"Quere","year":"2019","journal-title":"J Med Vasc"},{"issue":"6","key":"jrv250028r72","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report.","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"5","key":"jrv250028r73","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor\u2019s choice: European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases.","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"jrv250028r74","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.109101","article-title":"Anticoagulants for the treatment of isolated lower limb superficial vein thrombosis a Bayesian network meta-analysis of randomized controlled trials.","volume":"241","author":"Bontinis","year":"2024","journal-title":"Thromb Res"},{"issue":"1","key":"jrv250028r75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5758\/vsi.2018.34.1.1","article-title":"Extended-duration treatment of superficial vein thrombosis of the lower limbs with tinzaparin.","volume":"34","author":"Nikolakopoulos","year":"2018","journal-title":"Vasc Specialist Int"},{"key":"jrv250028r76","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.avsg.2024.01.009","article-title":"Superficial venous disease-an updated review.","volume":"105","author":"Anuforo","year":"2024","journal-title":"Ann Vasc Surg"},{"issue":"7","key":"jrv250028r77","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3390\/cancers15072034","article-title":"Three-month outcomes in cancer patients with superficial or deep vein thrombosis in the lower limbs: results from the RIETE Registry.","volume":"15","author":"Debourdeau","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"jrv250028r78","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1538-7836.2012.04704.x","article-title":"Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.","volume":"10","author":"Galanaud","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"6","key":"jrv250028r79","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jtha.2025.03.019","article-title":"The incidence and risk of venous thromboembolism in patients with active malignancy and isolated superficial venous thrombosis: a systematic review and meta-analysis (the IROVAM-iSVT review).","volume":"23","author":"Bailey","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"12","key":"jrv250028r80","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1055\/a-1414-5055","article-title":"Prognostic significance of concomitant superficial vein thrombosis in patients with deep vein thrombosis of the lower limbs.","volume":"121","author":"Dubois-Silva","year":"2021","journal-title":"Thromb Haemost"},{"issue":"17","key":"jrv250028r81","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2020.17272","article-title":"Diagnosis and treatment of lower extremity venous thromboembolism: a review.","volume":"324","author":"Chopard","year":"2020","journal-title":"JAMA"},{"key":"jrv250028r10","volume-title":"Virchow Triad","author":"Kushner","year":"2024"},{"key":"jrv250028r6","unstructured":"Rountree? KM, Barazi? H, Aulick? NF. Mondor disease. Accessed January 14, 2025. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30855866"},{"key":"jrv250028r15","unstructured":"Patel? SK, Surowiec? SM. Venous insufficiency. Accessed January 14, 2025. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28613694"},{"key":"jrv250028r59","unstructured":"Grigorian? A, Nahmias? JT. Upper extremity deep venous thrombosis. Accessed January 14, 2025. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29494027"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2838995\/jama_piazza_2025_rv_250028_1764782037.76064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:00:23Z","timestamp":1765296023000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2838995"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":81,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,12,9]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.15222","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}